{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T11:41:40Z","timestamp":1791632500680,"version":"4.3.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s11695-024-07505-w","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T01:02:20Z","timestamp":1726102940000},"page":"3790-3795","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Relationship between obesity severity and Helicobacter pylori eradication in patients undergoing bariatric and metabolic surgery: A post hoc analysis"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5817-3292","authenticated-orcid":false,"given":"Oscar","family":"Laudanno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Ahumar\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Thom\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Gollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"key":"7505_CR1","doi-asserted-by":"publisher","first-page":"706978","DOI":"10.3389\/fendo.2021.706978","volume":"12","author":"X Lin","year":"2021","unstructured":"Lin X, Li H. Obesity: epidemiology, pathophysiology, and therapeutics. Front Endocrinol (Lausanne). 2021;12:706978.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"Suppl_1","key":"7505_CR2","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1093\/advances\/nmy055","volume":"10","author":"B Caballero","year":"2019","unstructured":"Caballero B. Humans against obesity: who will win? Adv Nutr. 2019;10(Suppl_1):S4\u20139.","journal-title":"Adv Nutr."},{"issue":"8","key":"7505_CR3","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1056\/NEJMoa066603","volume":"357","author":"TD Adams","year":"2007","unstructured":"Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753\u201361.","journal-title":"N Engl J Med"},{"issue":"9","key":"7505_CR4","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1001\/jama.2020.12567","volume":"324","author":"DE Arterburn","year":"2020","unstructured":"Arterburn DE, Telem DA, Kushner RF, Courcoulas AP. Benefits and risks of bariatric surgery in adults: a review. JAMA. 2020;324(9):879\u201387.","journal-title":"JAMA"},{"issue":"SUPLEMENTO 1","key":"7505_CR5","first-page":"1","volume":"113","author":"DJL Harraca","year":"2021","unstructured":"Harraca DJL, Grigaites DAL, Mart\u00ednezDuartez P, Aguirre Ackermann M, Quevedo P, Musso C, Fuentes S, Salmeri E, Calder\u00f3n G, Roussos A, Far\u00edas JM, Ferraro AA, Bocanera L, Lerner M, Babor E, Fern\u00e1ndez E, Deluca L. Gorodner V (2021) Consenso Argentino Intersociedades de Cirug\u00eda Bari\u00e1trica y Metab\u00f3lica. Revista Argentina De Cirug\u00eda. 2021;113(SUPLEMENTO 1):1\u201370.","journal-title":"Revista Argentina De Cirug\u00eda."},{"issue":"3","key":"7505_CR6","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3748\/wjg.v20.i3.647","volume":"20","author":"M Carabotti","year":"2014","unstructured":"Carabotti M, D\u2019Ercole C, Iossa A, Corazziari E, Silecchia G, Severi C. Helicobacter pylori infection in obesity and its clinical outcome after bariatric surgery. World J Gastroenterol. 2014;20(3):647\u201353.","journal-title":"World J Gastroenterol"},{"key":"7505_CR7","doi-asserted-by":"crossref","unstructured":"American Society for Gastrointestinal Endoscopy Standards of Practice Committee, Evans JA, Muthusamy VR, Acosta RD, Bruining DH, Chandrasekhara V, Chathadi KV, Eloubeidi MA, Fanelli RD, Faulx AL, Fonkalsrud L, Khashab MA, Lightdale JR, Pasha SF, Saltzman JR, Shaukat A, Wang A, Stefanidis D, Richardson WS, Kothari SN, Cash BD. The role of endoscopy in the bariatric surgery patient. Gastrointest Endosc 2015; 81(5), 1063\u20131072.","DOI":"10.1016\/j.gie.2014.09.044"},{"issue":"12","key":"7505_CR8","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.soard.2022.08.013","volume":"18","author":"D Eisenberg","year":"2022","unstructured":"Eisenberg D, Shikora SA, Aarts E, et al. American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): indications for metabolic and bariatric surgery. Surg Obes Relat Dis. 2022;18(12):1345\u201356.","journal-title":"Surg Obes Relat Dis"},{"key":"7505_CR9","doi-asserted-by":"crossref","unstructured":"Doukas SG, Doukas PG, Vageli DP et al. Gastric cancer after bariatric bypass surgery. Do they relate? (a systematic review). Obes Surg 2023; 33: 1876-","DOI":"10.1007\/s11695-023-06567-6"},{"key":"7505_CR10","doi-asserted-by":"crossref","unstructured":"Gisbert JP, Alcedo J, Amador J et al. V Spanish Consensus Conference on Helicobacter pylori infection treatment. V Conferencia Espa\u00f1ola de Consenso sobre el tratamiento de la infecci\u00f3n por Helicobacter pylori. Gastroenterol Hepatol. 2022;45(5):392\u2013417.","DOI":"10.1016\/j.gastrohep.2021.07.011"},{"issue":"2","key":"7505_CR11","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/ajg.2016.563","volume":"112","author":"WD Chey","year":"2017","unstructured":"Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol. 2017;112(2):212\u201339.","journal-title":"Am J Gastroenterol"},{"key":"7505_CR12","doi-asserted-by":"crossref","unstructured":"Malfertheiner P, Megraud F, Rokkas T, Gisbert JP, Liou JM, Schulz C, Gasbarrini A, Hunt RH, Leja M, O'Morain C, Rugge M, Suerbaum S, Tilg H, Sugano K, El-Omar EM, European Helicobacter and Microbiota Study group. Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report. Gut 2022;71:1724\u20131762","DOI":"10.1136\/gutjnl-2022-327745"},{"issue":"3","key":"7505_CR13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/17425255.2018.1440287","volume":"14","author":"C Smit","year":"2018","unstructured":"Smit C, De Hoogd S, Br\u00fcggemann RJM, Knibbe CAJ. Obesity and drug pharmacology: a review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters. Expert Opin Drug Metab Toxicol. 2018;14(3):275\u201385.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"3","key":"7505_CR14","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/phar.2769","volume":"43","author":"L Meng","year":"2023","unstructured":"Meng L, Mui E, Ha DR, Stave C, Deresinski SC, Holubar M. Comprehensive guidance for antibiotic dosing in obese adults: 2022 update. Pharmacotherapy. 2023;43(3):226\u201346.","journal-title":"Pharmacotherapy"},{"key":"7505_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.52787\/KSMH4439","volume":"50","author":"O Laudanno","year":"2020","unstructured":"Laudanno O, Ahumar\u00e1n G, Thom\u00e9 M, Gollo P, Khoury M. Erradicaci\u00f3n del Helicobacter pylori en pacientes obesos pre-cirug\u00eda bari\u00e1trica. Acta Gastroenterol Latinoam. 2020;50:40\u20134.","journal-title":"Acta Gastroenterol Latinoam"},{"issue":"5","key":"7505_CR16","first-page":"345","volume":"113","author":"O Laudanno","year":"2021","unstructured":"Laudanno O, Ahumar\u00e1n G, Gollo P, Khoury M, Thom\u00e9 M, Gonz\u00e1lez P. Tailored Helicobacter pylori eradication therapy in obese patients undergoing bariatric surgery. Rev Esp Enferm Dig. 2021;113(5):345\u20137.","journal-title":"Rev Esp Enferm Dig"},{"key":"7505_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1146\/annurev-pharmtox-010814-124354","volume":"55","author":"CA Knibbe","year":"2015","unstructured":"Knibbe CA, Brill MJ, van Rongen A, Diepstraten J, van der Graaf PH, Danhof M. Drug disposition in obesity: toward evidence-based dosing. Annu Rev Pharmacol Toxicol. 2015;55:149\u201367.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"7505_CR18","first-page":"0000","volume":"84","author":"O Laudanno","year":"2024","unstructured":"Laudanno O, Ahumar\u00e1n G, Tom\u00e9 M, et al. Registro Argentino para el manejo de la infecci\u00f3n por Helicobacter pylori: an\u00e1lisis de la efectividad y seguridad de los esquemas de primera l\u00ednea de tratamiento. Medicina (B Aires). 2024;84:0000.","journal-title":"Medicina (B Aires)"},{"issue":"32","key":"7505_CR19","doi-asserted-by":"publisher","first-page":"4846","DOI":"10.3748\/wjg.v26.i32.4846","volume":"26","author":"TL Yan","year":"2020","unstructured":"Yan TL, Gao JG, Wang JH, Chen D, Lu C, Xu CF. Current status of Helicobacter pylori eradication and risk factors for eradication failure. World J Gastroenterol. 2020;26(32):4846\u201356.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"7505_CR20","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1002\/cpt.2181","volume":"109","author":"MP Pai","year":"2021","unstructured":"Pai MP. Antimicrobial dosing in specific populations and novel clinical methodologies: obesity. Clin Pharmacol Ther. 2021;109(4):942\u201351.","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"7505_CR21","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1007\/s11695-008-9477-z","volume":"18","author":"M Abdullahi","year":"2008","unstructured":"Abdullahi M, Annibale B, Capoccia D, et al. The eradication of Helicobacter pylori is affected by body mass index (BMI). Obes Surg. 2008;18(11):1450\u20134.","journal-title":"Obes Surg"},{"issue":"9","key":"7505_CR22","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s11695-010-0254-4","volume":"21","author":"RM Cerqueira","year":"2011","unstructured":"Cerqueira RM, Manso MC, Correia MR, et al. Helicobacter pylori eradication therapy in obese patients undergoing gastric bypass surgery\u2013fourteen days superior to seven days? Obes Surg. 2011;21(9):1377\u201381.","journal-title":"Obes Surg"},{"issue":"2","key":"7505_CR23","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s11695-017-3038-2","volume":"28","author":"R Pellicano","year":"2018","unstructured":"Pellicano R. Similar Helicobacter pylori eradication rate in obese patients undergoing gastric bypass surgery and in general population. Obes Surg. 2018;28(2):553\u20134.","journal-title":"Obes Surg"},{"issue":"2","key":"7505_CR24","doi-asserted-by":"publisher","first-page":"e12788","DOI":"10.1111\/hel.12788","volume":"26","author":"H Eto","year":"2021","unstructured":"Eto H, Suzuki S, Kusano C, et al. Impact of body size on first-line Helicobacter pylori eradication success using vonoprazan and amoxicillin dual therapy. Helicobacter. 2021;26(2):e12788.","journal-title":"Helicobacter"},{"issue":"3","key":"7505_CR25","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1053\/j.gastro.2022.05.055","volume":"163","author":"WD Chey","year":"2022","unstructured":"Chey WD, M\u00e9graud F, Laine L, L\u00f3pez LJ, Hunt BJ, Howden CW. Vonoprazan triple and dual therapy for Helicobacter pylori Infection in the United States and Europe: randomized clinical trial. Gastroenterology. 2022;163(3):608\u201319.","journal-title":"Gastroenterology"},{"issue":"3","key":"7505_CR26","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1053\/j.gastro.2022.06.076","volume":"163","author":"CA Fallone","year":"2022","unstructured":"Fallone CA. The current role of vonoprazan in Helicobacter pylori treatment. Gastroenterology. 2022;163(3):572\u20134.","journal-title":"Gastroenterology"},{"key":"7505_CR27","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/ygh2.494","volume":"3","author":"JY Kao","year":"2021","unstructured":"Kao JY, Almenoff JS, Portenier DD, Sheldon KL. Helicobacter pylori eradication by low-dose rifabutin triple therapy (RHB-105) is unaffected by high body mass index. GastroHep. 2021;3:426\u201334.","journal-title":"GastroHep"},{"key":"7505_CR28","doi-asserted-by":"crossref","unstructured":"Zhao X, Zhang Z, Lu F, et al. Effects of CYP2C19 genetic polymorphisms on the cure rates of H. pylori in patients treated with the proton pump inhibitors: an updated meta-analysis. Front Pharmacol. 2022; 13:938419.","DOI":"10.3389\/fphar.2022.938419"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-024-07505-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-024-07505-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-024-07505-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T10:12:41Z","timestamp":1728468761000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-024-07505-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["7505"],"URL":"https:\/\/doi.org\/10.1007\/s11695-024-07505-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4732297\/v1","asserted-by":"object"}]},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,12]]},"assertion":[{"value":"12 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}